Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Clinical trial NCT05642962 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05642962
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Ductal Adenocarcinoma Metastatic Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma Metastatic Pancreatic Carcinoma Pancreatic Carcinoma Pancreatic Carcinoma Metastatic Pancreatic Carcinoma Non-resectable Pancreatic Cancer Pancreatic Cancer Non-resectable Pancreatic Cancer Stage IV Pancreatic Cancer Metastatic PDAC

Start date: 2022-11-30
Primary completion: 2026-11-30
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.